204 related articles for article (PubMed ID: 31938020)
21. The lncRNA MEG3 downregulation leads to osteoarthritis progression via miR-16/SMAD7 axis.
Xu J; Xu Y
Cell Biosci; 2017; 7():69. PubMed ID: 29255591
[TBL] [Abstract][Full Text] [Related]
22. microRNA-134 inhibits melanoma growth and metastasis by negatively regulating collagen triple helix repeat containing-1 (CTHRC1).
Li Y; Fu Y; Gao Y; Li H; Ma L; Shu C; Li N; Ma C
Int J Clin Exp Pathol; 2018; 11(9):4319-4330. PubMed ID: 31949828
[TBL] [Abstract][Full Text] [Related]
23. LncRNA HCG18 facilitates melanoma progression by modulating miR-324-5p/CDK16 axis.
Zhang C; Lv H; Zhang F; Ji A
Am J Transl Res; 2022; 14(2):1246-1257. PubMed ID: 35273726
[TBL] [Abstract][Full Text] [Related]
24. LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis.
Zhang X; Wu N; Wang J; Li Z
J Cell Mol Med; 2019 Oct; 23(10):6708-6719. PubMed ID: 31328388
[TBL] [Abstract][Full Text] [Related]
25. Mechanism associated with aberrant lncRNA MEG3 expression in gestational diabetes mellitus.
Zhang H
Exp Ther Med; 2019 Nov; 18(5):3699-3706. PubMed ID: 31656536
[TBL] [Abstract][Full Text] [Related]
26. miR-506 attenuates methylation of lncRNA
Wang XX; Guo GC; Qian XK; Dou DW; Zhang Z; Xu XD; Duan X; Pei XH
Cancer Cell Int; 2018; 18():171. PubMed ID: 30386180
[TBL] [Abstract][Full Text] [Related]
27. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
[TBL] [Abstract][Full Text] [Related]
28. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
Li CF; Li YC; Wang Y; Sun LB
Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464
[TBL] [Abstract][Full Text] [Related]
29. lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.
Dai Y; Wan Y; Qiu M; Wang S; Pan C; Wang Y; Ou J
Cell Physiol Biochem; 2018; 51(6):2872-2886. PubMed ID: 30562741
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211.
Ji L; Li X
J Cell Physiol; 2019 Dec; 234(12):22911-22920. PubMed ID: 31124134
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cancer Biol Ther; 2018; 19(11):1039-1056. PubMed ID: 30461333
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of lncRNA MEG3 inhibits viability, migration, and invasion and promotes apoptosis by sponging miR-127 in osteosarcoma cell.
Wang Y; Kong D
J Cell Biochem; 2018 Jan; 119(1):669-679. PubMed ID: 28636101
[TBL] [Abstract][Full Text] [Related]
33. m6A-Induced LncRNA MEG3 Suppresses the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cell Through miR-544b/BTG2 Signaling.
Wu J; Pang R; Li M; Chen B; Huang J; Zhu Y
Onco Targets Ther; 2021; 14():3745-3755. PubMed ID: 34163177
[TBL] [Abstract][Full Text] [Related]
34. LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis.
Wang P; Chen D; Ma H; Li Y
Onco Targets Ther; 2017; 10():5137-5149. PubMed ID: 29123412
[TBL] [Abstract][Full Text] [Related]
35. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11.
Liu Z; Chen JY; Zhong Y; Xie L; Li JS
Braz J Med Biol Res; 2019; 52(10):e8631. PubMed ID: 31531526
[TBL] [Abstract][Full Text] [Related]
36. Long Non-Coding RNA MEG3 Functions as a Competing Endogenous RNA to Regulate HOXA11 Expression by Sponging miR-181a in Multiple Myeloma.
Shen X; Bai H; Zhu H; Yan Q; Yang Y; Yu W; Shi Q; Wang J; Li J; Chen L
Cell Physiol Biochem; 2018; 49(1):87-100. PubMed ID: 30134227
[TBL] [Abstract][Full Text] [Related]
37. Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21.
Zhang LL; Hu D; Zou LH
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8315-8323. PubMed ID: 30556872
[TBL] [Abstract][Full Text] [Related]
38. LncRNA SNHG6 regulating Hedgehog signaling pathway and affecting the biological function of gallbladder carcinoma cells through targeting miR-26b-5p.
Liu XF; Wang K; Du HC
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7598-7611. PubMed ID: 32744686
[TBL] [Abstract][Full Text] [Related]
39. LncRNA MEG3 suppressed the progression of ovarian cancer via sponging miR-30e-3p and regulating LAMA4 expression.
Liu Y; Xu Y; Ding L; Yu L; Zhang B; Wei D
Cancer Cell Int; 2020; 20():181. PubMed ID: 32489317
[TBL] [Abstract][Full Text] [Related]
40. LncRNA MEG3 enhances
Liu Y; Yue P; Zhou T; Zhang F; Wang H; Chen X
Biomed Pharmacother; 2018 Sep; 105():1232-1239. PubMed ID: 30021359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
